Biología Molecular e Ingeniería Bioquímica
Departamento
![Foto de Manuel](/img/nophoto.png)
Manuel
Romero-Gómez
Publicaciones en las que colabora con Manuel Romero-Gómez (18)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Non-pharmacological treatment approach in patients with metabolic dysfunction-associated liver disease
Comprehensive Guide to Hepatitis Advances (Elsevier), pp. 343-367
-
Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention
BMJ
2022
-
Assessing the Impact of SARS-CoV-2 Lineages and Mutations on Patient Survival
Viruses, Vol. 14, Núm. 9
-
Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective
Seminars in Liver Disease, Vol. 42, Núm. 4, pp. 434-445
-
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
Scientific Reports, Vol. 12, Núm. 1
2021
-
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
Frontiers in Immunology, Vol. 12
-
Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr−/−.Leiden mice without attenuation of steatohepatitis
Scientific Reports, Vol. 11, Núm. 1
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
-
Dietary Approach to NAFLD
Non-Alcoholic Fatty Liver Disease: A 360-degree Overview (Springer International Publishing), pp. 271-287
-
The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management
Liver International, Vol. 40, Núm. S1, pp. 102-108
2019
-
Co-03. La ldl oxidada es un biomarcador distintivo de la presencia de esteatohepatitis frente a fibrosis hepática en enfermedad hepática metabólica grasa
Revista andaluza de patología digestiva, Vol. 42, Núm. 5, pp. 199-199
-
Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models
Revista Espanola de Enfermedades Digestivas, Vol. 111, Núm. 4, pp. 301-307
2018
-
Co-21. Uso de microarns como biomarcadores no invasivos en enfermedad hepática metabólica por depósito de grasa no alcohólica
Revista andaluza de patología digestiva, Vol. 41, Núm. 5, pp. 289-290
2017
-
An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat “Western-type” diet in mice
Molecular Nutrition and Food Research, Vol. 61, Núm. 3
-
Co-12. Papel del factor de crecimiento de fibroblasto 21 (fgf21) en pacientes con eghna: Estudio genético y funcional.
Revista andaluza de patología digestiva, Vol. 40, Núm. 5, pp. 277-277
2010
-
Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: A cohort study
Annals of Internal Medicine, Vol. 153, Núm. 5, pp. 281-288